Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Abbott Receives CE Mark for Alinity Molecular Diagnostics System, Assays

Abbott Receives CE Mark for Alinity Molecular Diagnostics System, Assays

Mar 19, 2019
|
staff reporter

NEW YORK (GenomeWeb) – Abbott announced today that it has received CE marking for its Alinity m molecular diagnostics system and assays, which are now available in countries that recognize the designation.

The firm said that its molecular system will help clinicians who are struggling to keep up with demand for infectious disease testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. Credo Diagnostics Combo Influenza, COVID-19 Test Receives CE-IVD Mark

  2. Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC

  3. DiaSorin High-Throughput, Rapid Antigen SARS-CoV-2 Test Gets CE Mark

  4. Agena Bioscience Gets FDA Emergency Use Authorization for MassArray Coronavirus Test

  5. Ortho Clinical Diagnostics Gets CE Mark for High-Throughput SARS-CoV-2 Antigen Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.